Publication date: 15th December 2025
Organic electrochemical transistors (OECTs) are key bioelectronic devices, with applications ranging from biosensors, electrophysiological monitoring, flexible electronics, etc. To date, OECTs have been designed to provide the best possible performance and long-term stability. However, the rise of transient electronics has set a new demand for bioelectronics: the need to combine stable performance under physiological conditions (e.g., humidity, temperature) with safe, controlled degradation into non-toxic products.
While tremendous advances have been made in biodegradable insulating polymers, solutions toward degradable conjugated polymers are still lacking. Recent studies showed that acid-labile imine bonds (C=N) provide degradation under hydrolytic conditions[1,2], but lead to lower mobility compared to state-of-the-art materials and often results in degradation products with known toxicity.
Inspired by recent work in degradable conjugated polymer nanoparticles[3,4], we investigated the enzymatic degradation of a conjugated polymers thin films designed for OECTs. Our work focuses on n-type donor–acceptor polymers with established performances. Here, we show that thin films degrade via the action of hypochlorous acid (HOCl), a reactive oxygen species released by myeloperoxidase: an enzyme produced by immune cells.[5]
We then used UV–Vis spectroscopy, NMR, and mass spectrometry to elucidate the degradation mechanism in presence of HOCl. High-resolution mass spectrometry coupled with machine learning analysis enabled to identify degradation products and evaluate their potential toxicity.
Overall, our results present a new concept of enzymatically degradable high performance conjugated polymers for OECTs.
